{"id":481536,"title":"Notice: Multiple Additions to the Prescription Drug List (PDL) [2023-03-08] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:55:57.182000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/mutliple-additions-2023-03-08.html?wbdisable=true","snippet":"Notice: Multiple Additions to the Prescription Drug List (PDL) [2023-03-08] March 8, 2023 Our file number: 23-101719-215 The purpose of this Notice of Amendment is to notify about the addition of cangrelor, ciltacabtagene autoleucel, deucravacitinib, pegcetacoplan and tirzepatide…","rawSnapshotUrl":"/api/snapshots/raw/481536","browseUrl":"https://replay.healtharchive.ca/job-6/20260106165557/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/mutliple-additions-2023-03-08.html?wbdisable=true#ha_snapshot=481536","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}